Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing

OBJECTIVES: Venous thromboembolism (VTE) is a major potential complication following orthopaedic surgery. Subcutaneously administered enoxaparin has been used as the benchmark to reduce the incidence of VTE. However, concerns have been raised regarding the long-term administration of enoxaparin and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Joint Res
Autors principals: Pilge, H., Fröbel, J., Prodinger, P. M., Mrotzek, S. J., Fischer, J. C., Zilkens, C., Bittersohl, B., Krauspe, R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4852789/
https://ncbi.nlm.nih.gov/pubmed/26989119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1302/2046-3758.53.2000595
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars